Syngene International shares surge 12%, biggest 1-day gain in 6 years; what drove the rally despite a Q2 profit drop?

Syngene International reported ₹32.2 crore, with movement of 12% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.

Against that, the stock is +1.0% on the day at ₹402.70, and has returned +0.9% over three months. It sits 39% below its 52-week high, which means a good deal of bad news was already in the price. The pharma & healthcare sector has moved -0.9% over the same period, so Syngene International is running 1.8 points ahead of its peers.

For Syngene International, the question is how much of this is already reflected in the price and how much re-rates the pharma & healthcare peer set alongside it.